These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33689917)

  • 1. Expectant management of retained products of conception following abortion: A retrospective cohort study.
    Wada Y; Takahashi H; Suzuki H; Ohashi M; Ogoyama M; Nagayama S; Baba Y; Usui R; Suzuki T; Ohkuchi A; Fujiwara H
    Eur J Obstet Gynecol Reprod Biol; 2021 May; 260():1-5. PubMed ID: 33689917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Reproductive Outcomes following Retained Products of Conception after Vaginal Delivery versus First-Trimester Abortion.
    Melcer Y; Smorgick N; Schneider D; Pansky M; Halperin R; Ben-Ami I
    Gynecol Obstet Invest; 2015; 80(3):206-10. PubMed ID: 26088169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive pills as an option for non-surgical management of retained products of conception - a preliminary study.
    Hershko Klement A; Frederic M; Bentov Y; Chang P; Nayot D; Haas J; Casper RF
    Gynecol Endocrinol; 2018 Jul; 34(7):609-611. PubMed ID: 29345165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expectant therapy versus curettage for retained products of conception after second trimester termination of pregnancy: analysis of outcomes and complications].
    Zeng WJ; An SL; Huang H; Huang QT; Li FF; Wang HZ; Cai DC; Gao YF
    Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):569-574. PubMed ID: 28539276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative management for retained products of conception after less than 22 weeks of gestation.
    Shitanaka S; Chigusa Y; Kawahara S; Kawasaki K; Mogami H; Mandai M; Kondoh E
    J Obstet Gynaecol Res; 2020 Oct; 46(10):1982-1987. PubMed ID: 32761752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of pregnancy-related enhanced myometrial vascularity following miscarriage.
    Grewal K; Al-Memar M; Fourie H; Stalder C; Timmerman D; Bourne T
    Ultrasound Obstet Gynecol; 2020 May; 55(5):676-682. PubMed ID: 31503383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative management of retained products of conception in the normal placental position: A retrospective observational study.
    Takahashi H; Ohhashi M; Baba Y; Nagayama S; Ogoyama M; Horie K; Suzuki H; Usui R; Ohkuchi A; Matsubara S
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():87-92. PubMed ID: 31238204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the time interval between the diagnosis to hysteroscopic evacuation of retained products of conception affect reproductive outcome?
    Tarasov M; Burke YZ; Stockheim D; Orvieto R; Cohen SB
    Arch Gynecol Obstet; 2020 Dec; 302(6):1523-1528. PubMed ID: 32785781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of using vaginal misoprostol for treatment of retained products of conception after first trimester miscarriage: a retrospective cohort study.
    Stewart KT; Lee JS; Pan K; Albert AY; Fisher S
    Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):474-479. PubMed ID: 32869658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonographic vascularity assessment for predicting future severe hemorrhage in retained products of conception after second-trimester abortion.
    Akiba N; Iriyama T; Nakayama T; Seyama T; Sayama S; Kumasawa K; Komatsu A; Yabe S; Nagamatsu T; Osuga Y; Fujii T
    J Matern Fetal Neonatal Med; 2021 Feb; 34(4):562-568. PubMed ID: 31006292
    [No Abstract]   [Full Text] [Related]  

  • 11. The RPOC long axis is a simple indicator for predicting the need of invasive strategies for secondary postpartum hemorrhage in either post-abortion or post-partum women: a retrospective case control study.
    Kobayashi M; Nakagawa S; Kawanishi Y; Masuda T; Maenaka T; Toda A; Miyake T; Hiramatsu K; Miyoshi A; Mimura K; Kimura T; Endo M; Kimura T
    BMC Pregnancy Childbirth; 2021 Sep; 21(1):653. PubMed ID: 34560846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hysteroscopic Removal of Retained Products of Conception Implanted Over a Focal Area of Adenomyosis: A Case Report.
    Alonso L; Nieto L; Carugno J
    J Minim Invasive Gynecol; 2018; 25(3):382-383. PubMed ID: 28939480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonographic Findings of Vascular Signals for Retained Products of Conception in Women Following First-Trimester Termination of Pregnancy.
    Lin F; Chen Z; Tao H; Ren X; Ma P; Lash GE; Shuai H; Li P
    J Obstet Gynaecol Can; 2024 Mar; 46(3):102266. PubMed ID: 37940040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retained products of conception (RPOC) following delivery without placenta previa: Which patients with RPOC show postpartum hemorrhage?
    Takahashi H; Tanaka H; Osuga Y; Miura K; Saito S; Sato S; Sugawara J; Ide S; Koh I; Yamauchi K; Okuyama A; Okuno K; Kuwata T; Fujieda S; Ikeda T
    Placenta; 2022 Jun; 124():12-17. PubMed ID: 35580405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of estrogen-progestogen therapy for women with vascular retained products of conception following miscarriage or abortion.
    Yamaguchi M; Nishimura A; Motohara T; Ohba T; Kondoh E
    Taiwan J Obstet Gynecol; 2023 Sep; 62(5):661-666. PubMed ID: 37678992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancies Following Hysteroscopic Removal of Retained Products of Conception after Delivery Versus Abortion.
    Ganer Herman H; Kogan Z; Tairy D; Ben Zvi M; Kerner R; Ginath S; Bar J; Sagiv R
    Gynecol Obstet Invest; 2018; 83(6):586-592. PubMed ID: 29945122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infertility Following Retained Products of Conception: Does the Timing of Surgical Intervention Matter?
    Melcer Y; Smorgick N; Schneider D; Pansky M; Halperin R; Ben-Ami I
    Isr Med Assoc J; 2016 Oct; 18(10):605-608. PubMed ID: 28471620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retained products of conception: What is the risk for recurrence on subsequent pregnancies?
    Smorgick N; Mittler A; Ben-Ami I; Maymon R; Vaknin Z; Pansky M
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():1-5. PubMed ID: 29525517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-step hysteroscopy for management of morbidly adherent retained products of conception.
    Smorgick N; Rabinovitch I; Levinsohn-Tavor O; Maymon R; Vaknin Z; Pansky M
    Arch Gynecol Obstet; 2019 Sep; 300(3):669-674. PubMed ID: 31321494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Office Operative Hysteroscopy for the Management of Retained Products of Conception.
    Mohr-Sasson A; Gur T; Meyer R; Mashiach R; Stockheim D
    Reprod Sci; 2022 Mar; 29(3):761-767. PubMed ID: 35020188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.